BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24970932)

  • 1. HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.
    Fernandez CA; Smith C; Yang W; Daté M; Bashford D; Larsen E; Bowman WP; Liu C; Ramsey LB; Chang T; Turner V; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Onengut-Gumuscu S; Chen WM; Concannon P; Rich SS; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Relling MV
    Blood; 2014 Aug; 124(8):1266-76. PubMed ID: 24970932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.
    Kutszegi N; Yang X; Gézsi A; Schermann G; Erdélyi DJ; Semsei ÁF; Gábor KM; Sági JC; Kovács GT; Falus A; Zhang H; Szalai C
    Haematologica; 2017 Sep; 102(9):1578-1586. PubMed ID: 28596278
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Liu S; Gao C; Wu Y; Lin W; Li J; Xue T; Wang L; Zheng H; Zhang R
    Pharmacogenomics; 2021 Nov; 22(17):1135-1142. PubMed ID: 34747637
    [No Abstract]   [Full Text] [Related]  

  • 4. Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.
    Fernandez CA; Smith C; Yang W; Mullighan CG; Qu C; Larsen E; Bowman WP; Liu C; Ramsey LB; Chang T; Karol SE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Jeha S; Pui CH; Evans WE; Devidas M; Relling MV
    Blood; 2015 Jul; 126(1):69-75. PubMed ID: 25987655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparaginase allergies: it's all in the genes.
    Wetzler M
    Blood; 2014 Aug; 124(8):1206-7. PubMed ID: 25147374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA alleles associated with asparaginase hypersensitivity in Chinese children.
    Chua GT; Rosa Duque JS; Cheuk DKL; Leung AWK; Wong WHS; Liu APY; Lee PPW; Ha SY; Chiang AKS; Ho MHK; Chu WK; Chan YS; Luk CW; Ling ASC; Kwan MYW; Yiu OKF; Wong ICK; Lau YL; Li CK; Leung WH; Chan GCF; Ip P; Kwok J
    J Hematol Oncol; 2021 Oct; 14(1):182. PubMed ID: 34717720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium.
    Gagné V; St-Onge P; Beaulieu P; Laverdière C; Leclerc JM; Tran TH; Sallan SE; Neuberg D; Silverman LB; Sinnett D; Krajinovic M
    Pharmacogenomics; 2020 Jun; 21(8):541-547. PubMed ID: 32372697
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia.
    Rajić V; Debeljak M; Goričar K; Jazbec J
    Leuk Lymphoma; 2015; 56(11):3103-8. PubMed ID: 25697915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis.
    Singh T; Fakiola M; Oommen J; Singh AP; Singh AK; Smith N; Chakravarty J; Sundar S; Blackwell JM
    J Immunol; 2018 Apr; 200(8):2727-2737. PubMed ID: 29507109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity.
    Liu Y; Yang W; Smith CA; Cheng C; Karol SE; Larsen EC; Winick N; Carroll WL; Loh ML; Raetz EA; Hunger SP; Winter SS; Dunsmore KP; Devidas M; Yang JJ; Evans WE; Jeha S; Pui CH; Inaba H; Relling MV
    Clin Pharmacol Ther; 2021 Sep; 110(3):794-802. PubMed ID: 33768542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA class II alleles/haplotypes and amino acid variations in the peptide binding pockets with rheumatoid arthritis.
    Chinniah R; Rajendran MS; Sivanadham R; Adaikalam ML; Ravi PM; Vijayan M; Boopathy S; Pandi S; Sevak V; Karuppiah B
    Int J Rheum Dis; 2019 Aug; 22(8):1553-1562. PubMed ID: 31169355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Frequency of HLA-A, HLA-B, and HLA-DRB1 Alleles in Patients with Acute Lymphoblastic Leukemia in the Turkish Population: A Case-Control Study.
    Patıroğlu T; Akar HH
    Turk J Haematol; 2016 Dec; 33(4):339-345. PubMed ID: 27095065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
    Kurtzberg J; Asselin B; Bernstein M; Buchanan GR; Pollock BH; Camitta BM
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):610-6. PubMed ID: 22042277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
    Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
    Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged
    Mondelaers V; Suciu S; De Moerloose B; Ferster A; Mazingue F; Plat G; Yakouben K; Uyttebroeck A; Lutz P; Costa V; Sirvent N; Plouvier E; Munzer M; Poirée M; Minckes O; Millot F; Plantaz D; Maes P; Hoyoux C; Cavé H; Rohrlich P; Bertrand Y; Benoit Y;
    Haematologica; 2017 Oct; 102(10):1727-1738. PubMed ID: 28751566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic approach demonstrates enrichment of multiple interactions between non-
    Diaz-Gallo LM; Ramsköld D; Shchetynsky K; Folkersen L; Chemin K; Brynedal B; Uebe S; Okada Y; Alfredsson L; Klareskog L; Padyukov L
    Ann Rheum Dis; 2018 Oct; 77(10):1454-1462. PubMed ID: 29967194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.
    Finch ER; Smith CA; Yang W; Liu Y; Kornegay NM; Panetta JC; Crews KR; Molinelli AR; Cheng C; Pei D; Ramsey LB; Karol SE; Inaba H; Sandlund JT; Metzger M; Evans WE; Jeha S; Pui CH; Relling MV
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28040. PubMed ID: 31612640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia.
    Liu C; Kawedia JD; Cheng C; Pei D; Fernandez CA; Cai X; Crews KR; Kaste SC; Panetta JC; Bowman WP; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
    Leukemia; 2012 Nov; 26(11):2303-9. PubMed ID: 22484422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients.
    Wang B; Relling MV; Storm MC; Woo MH; Ribeiro R; Pui CH; Hak LJ
    Leukemia; 2003 Aug; 17(8):1583-8. PubMed ID: 12886246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report.
    Ko RH; Jones TL; Radvinsky D; Robison N; Gaynon PS; Panosyan EH; Avramis IA; Avramis VI; Rubin J; Ettinger LJ; Seibel NL; Dhall G
    Cancer; 2015 Dec; 121(23):4205-11. PubMed ID: 26308766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.